Federal Judge Recommends Jury Trial in Bausch & Lomb Patent Dispute Over Eye Vitamins

The ongoing legal battle between Bausch & Lomb and the maker of MacularProtect eye care products saw a new development this week. A federal magistrate judge in Delaware recommended that the case proceed to a jury trial. The crux of the conflict centers around allegations that MacularProtect infringed upon Bausch & Lomb’s patents associated with its PreserVision eye vitamins. The judge’s decision was influenced by a legal doctrine that allows patent holders to claim infringement if a contested product bears significant similarities to an existing patented invention. The implications for patent law interpretation, particularly within the pharmaceutical sector, could be substantial as the case progresses. For more detailed coverage, the [original report](https://www.law360.com/articles/2312215/magistrate-finds-bausch-eye-vitamin-case-should-go-to-jury) sheds light on the judge’s remarks and the legal arguments that could shape the jury’s considerations.